Skip to main content

Month: June 2022

Vista’s North American Footprint Doubles Following the Closing of Jet Edge Acquisition

Vista Closing of Jet Edge Acquisition Jet Edge, hangarThe acquisition significantly enhances and cements Vista’s position as the #1 on demand operator globally; Clients will have access to an additional 100 aircraft, including the largest on demand fleet of Gulfstream jets in the U.S., and will benefit from access to a combined global Group fleet of over 350 aircraft; Jet Edge teams of over 800 experts will seamlessly join Vista; Provides additional flexibility and infrastructure, including a maintenance facility, to support Vista’s enhanced scale, at a time of unprecedented demand for business aviation; This follows the successful closing of the Air Hamburg acquisition in May 2022.New York, June 16, 2022: Vista Global Holding (Vista), the world’s leading private aviation group, has significantly enhanced its position in the U.S....

Continue reading

Orezone Announces Results of Annual General and Special Meeting

VANCOUVER, British Columbia, June 16, 2022 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”) reports that all resolutions at the Company’s annual general and special meetings of shareholders were approved by shareholders. The results of voting are noted below. For additional details on the resolutions, please see the Management Information Circular of the Company dated May 13, 2022.    1.  To fix the number of directors at eight:For % For Against % Against146,174,622 99.85% 217,826 0.15%2.  To elect directors of the Company:Nominee For % For Withhold % WithholdStephen Axcell 146,185,340 99.86% 207,108 0.14%Joseph Conway 145,095,652 99.11% 1,296,796 0.89%Patrick Downey 139,618,954 95.37% 6,773,494 4.63%Robert Doyle 146,197,507 99.87% 194,941 0.13%Michael...

Continue reading

Middlefield Canadian Income PCC – Result of AGM

Middlefield Canadian Income PCC (the “Company”) and Middlefield Canadian Income – GBP PC (the “Cell“) Results of General Meetings The Company on behalf of the Cell hereby announces that at the Cell Annual General Meeting held on Thursday, 16 June, 2022 at 11.30 a.m. all the resolutions relating to both the ordinary business and the special business, as set out in the notice of meeting dated 14 April, 2022, were duly passed on a poll and voting was as set out in the table below.  Votes in favour* % of votes cast in favour Votes against* % of votes cast against % of issued shares voting** Votes withheld* % of issued shares withheld**  No. shares % No. shares % % No. shares %Special Resolution 1 43,923,527 99.97 14,337 0.03 41.26 9,037 0.01Special Resolution 2 41,893,653 95.35 2,044,211 4.65 41.26 9,037 0.01Ordinary...

Continue reading

Delta 9 Announces Closing of Public Offering of Equity Units

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES WINNIPEG, Manitoba, June 16, 2022 (GLOBE NEWSWIRE) — Delta 9 Cannabis Inc. (“Delta 9” or the “Company”) (TSX:DN) (OTCQX: DLTNF) is pleased to announce the closing (the “Closing”) of its previously announced overnight marketed financing of units of the Company (the “Equity Units”) at a price of $0.22 per Equity Unit (the “Offering Price”) for aggregate gross proceeds of approximately $1,936,006 (the “Offering”). The Offering was conducted and led by Research Capital Corporation as sole agent and sole bookrunner (the “Agent”). The net proceeds received by the Company from the Offering will be used for working capital and general corporate purposes. Each Equity Unit consists of one common share of the Company (a “Common Share”) and one Common Share...

Continue reading

SUMR Brands Stockholders Approve Acquisition by Kids2

WOONSOCKET, R.I., June 16, 2022 (GLOBE NEWSWIRE) — Summer Infant, Inc., doing business as SUMR Brands (“SUMR Brands” or the “Company”) (NASDAQ: SUMR), today announced that its stockholders have voted at a special meeting to adopt the previously announced definitive merger agreement pursuant to which the Company will be acquired by Kids2, Inc. The final voting results for each proposal voted on at the special meeting will be set forth in a Form 8-K filed by the Company with the U.S. Securities and Exchange Commission. “We want to thank our stockholders for their support of our transaction with Kids2,” said Stuart Noyes, the Company’s CEO. “Their vote of confidence was pivotal to closing this transaction, which will benefit our channel customers and, ultimately, the end consumers they serve.” The closing of the transaction is expected...

Continue reading

MICT Receives In-Principal Approval of Capital Markets Services License from the Monetary Authority of Singapore

The Final CMS License, Expected in the Coming Weeks, Will Allow MICT to Roll Out its ‘Magpie Invest’ Proprietary Stock Trading App Throughout the Singapore Market While Also Enabling it to Expand its Product Range MONTVALE, N.J., June 16, 2022 (GLOBE NEWSWIRE) — MICT Inc.’s (Nasdaq: MICT), (the “Company”) subsidiary, Magpie Securities (Singapore) PTE Limited, today announces it has received in-principal approval of a Capital Markets License (“CMS License”) from the Monetary Authority of Singapore (“MAS”). The issuance of the final CMS License is expected from MAS subject to the satisfaction of certain conditions, which Magpie Securities (Singapore) PTE Limited expects to achieve within the coming small number of weeks. The CMS License application forms part of the Company’s international expansion and roll out strategy for its...

Continue reading

3DX Industries Inc. Update on Corporate Developments

Seattle, WA, June 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — 3DX Industries Inc. (OTCM: DDDX) (“3DX” or the “Company”), an advanced manufacturing corporation, held its annual shareholders event earlier last week to highlight the progress made over the past year along with a guided tour of the 3DX manufacturing facility.  “We had over 50 people in attendance and considering it was the first of its kind for 3DX, we were pleased with the turn out,” stated Company President Roger Janssen. “It was great to meet some of our existing shareholders as well as potential investors, who took the time to get a better understanding of 3DX and the progress we have made over the past year.”  After the presentation the attendees were taken to the company’s manufacturing facility for a tour of current operations. “We felt it was important...

Continue reading

Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors

Appointment of Independent Director Builds Upon Biotech Expertise Boca Raton, FL, June 16, 2022 (GLOBE NEWSWIRE) — Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for rare diseases and conditions, announced today that Lawrence S. Zaslow has joined its Board of Directors as an independent director and will chair its Compensation Committee. Mr. Zaslow co-founded BioTheryX, Inc. (https://biotheryx.com/about-us/), a leader in protein degradation technology, along with three Celgene scientists, including David Stirling, co-founder of Celgene. In addition to being a founder, Mr. Zaslow also served as a director and president, over a period of fifteen years. During his tenure at BioTheryX Mr. Zaslow had primary responsibility for:Strategic...

Continue reading

Genetron Health to Participate in the Goldman Sachs Healthcare Corporate Day

BEIJING, June 16, 2022 (GLOBE NEWSWIRE) — Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that management will be participating in the virtual Goldman Sachs Healthcare Corporate Day. Genetron’s management team, Sizhen Wang, co-founder and Chief Executive Officer and Evan Xu, Chief Financial Officer, will attend investor meetings on Friday, June 24, 2022. Interested parties may request more information by contacting their sales representative at Goldman Sachs. About Genetron Holdings LimitedGenetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH) is a leading precision oncology platform...

Continue reading

RENNOVA HEALTH, INC. DISCUSSES PROGRESS AND PLANS FOR MENTAL AND BEHAVIORAL HEALTH DIVISION WITH THE STOCK DAY PODCAST

WEST PALM BEACH, Fla., June 16, 2022 (GLOBE NEWSWIRE) — Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan joined Stock Day host Sever Copley to discuss progress with the business and the Company’s plans to develop a mental and behavioral health division. Copley started off by asking about the performance of the current hospital operations. Lagan stated his belief that the business was now stabilized, helped by the recently secured Critical Access Designation, and that he believed the operations would now be cash flow positive and generate a profit. Copley went on to ask about the status of previously discussed plans to add mental and behavioral health to the business. Lagan confirmed that a new division, Myrtle Recovery Centers, Inc., had been created and that the Company was finalizing a plan to utilize available...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.